Clinico-pathological feature | Â | Frequency n (%) |
---|---|---|
Gender (n = 381) | Female | 175 (45.9) |
 | Male | 206 (54.1) |
Tumour location (n = 369) | Left-sided | 242 (65.6) |
 | Right-sided | 127 (34.4) |
pT stage (n = 373) | pT1-2 | 86 (23.1) |
 | pT3-4 | 287 (76.9) |
pN stage (n = 357) | pN0 | 178 (49.9) |
 | pN1-2 | 179 (50.1) |
Tumour grade (n = 374) | G1-2 | 289 (77.3) |
 | G3 | 85 (22.7) |
Vascular invasion (n = 374) | Absent | 267 (71.4) |
 | Present | 107 (28.6) |
Tumour border configuration (n = 374) | Pushing | 195 (52.1) |
 | Infiltrating | 179 (47.9) |
Peritumoural lymphocytic infiltration (n = 374) | Absent | 308 (82.4) |
 | Present | 66 (17.7) |
Local recurrence (n = 377) | Absent | 208 (55.2) |
 | Present | 169 (44.8) |
Liver metastasis (n = 387) | Absent | 313 (80.9) |
 | Present | 74 (19.1) |
Post-operative therapy (n = 377) | No | 289 (76.7) |
 | Yes | 88 (23.3) |
Survival time (n = 377) | 5-year (%) (95%CI) | 58.9 (52-65) |